Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection.

Banfield BW, Leduc Y, Esford L, Visalli RJ, Brandt CR, Tufaro F.

Virology. 1995 Apr 20;208(2):531-9.

2.
3.
5.

Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells.

Bergefall K, Trybala E, Johansson M, Uyama T, Naito S, Yamada S, Kitagawa H, Sugahara K, Bergström T.

J Biol Chem. 2005 Sep 16;280(37):32193-9. Epub 2005 Jul 18.

6.

Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.

Marchetti M, Trybala E, Superti F, Johansson M, Bergström T.

Virology. 2004 Jan 5;318(1):405-13.

7.

Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity.

Uyama T, Ishida M, Izumikawa T, Trybala E, Tufaro F, Bergström T, Sugahara K, Kitagawa H.

J Biol Chem. 2006 Dec 15;281(50):38668-74. Epub 2006 Oct 13.

9.

Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells.

Mårdberg K, Trybala E, Tufaro F, Bergström T.

J Gen Virol. 2002 Feb;83(Pt 2):291-300.

PMID:
11807221
10.

Human herpesvirus 8 interaction with target cells involves heparan sulfate.

Akula SM, Wang FZ, Vieira J, Chandran B.

Virology. 2001 Apr 10;282(2):245-55.

11.

Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.

Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, Miyasaka M.

J Biol Chem. 2000 Nov 10;275(45):35448-56.

12.

Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.

Volpi N, Petrini M, Conte A, Valentini P, Venturelli T, Bolognani L, Ronca G.

Exp Cell Res. 1994 Nov;215(1):119-30.

PMID:
7957660
13.

Characterization of ryudocan glycosaminoglycan acceptor sites.

Shworak NW, Shirakawa M, Mulligan RC, Rosenberg RD.

J Biol Chem. 1994 Aug 19;269(33):21204-14.

14.

Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.

Bender FC, Whitbeck JC, Lou H, Cohen GH, Eisenberg RJ.

J Virol. 2005 Sep;79(18):11588-97.

15.

Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation.

Almeida PC, Nantes IL, Chagas JR, Rizzi CC, Faljoni-Alario A, Carmona E, Juliano L, Nader HB, Tersariol IL.

J Biol Chem. 2001 Jan 12;276(2):944-51.

17.

Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

Rux AH, Lou H, Lambris JD, Friedman HM, Eisenberg RJ, Cohen GH.

Virology. 2002 Mar 15;294(2):324-32.

18.

Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.

Vischer P, Feitsma K, Schön P, Völker W.

Eur J Cell Biol. 1997 Aug;73(4):332-43.

PMID:
9270876

Supplemental Content

Support Center